Abstract:Abstract Objectives Red raspberry (RR) polyphenols, including ellagic acid and their gut-derived metabolites, the urolithins, reduce inflammation and improve insulin sensitivity. However, it is unknown whether the gut microbiota is responsible for these health benefits and why certain individuals do not transform ellagic acid into urolithins. Here, we determined the causative role for the microbiome in mediating the health benefits from RR polyphenols using germ-free and conventionalized mouse models of diet-induced obesity. We also tested whether Gordonibacter urolithinfaciens (G. uro), a gut microbe previously shown to metabolize ellagic acid into urolithins, could enhance metabolic benefits when administered as a synbiotic with RR polyphenols. Methods RR polyphenols were extracted using a macroporous ion-exchange resin column to remove sugars and fibers. C3H/HeN mice with (CVZ) or without a microbiota (GF) were fed either a low fat (LF), high fat (HF), or HF diet with RR polyphenols (HF + RR) for 12 weeks. For synbiotic studies, GF C57BL/6 mice were given a G. uro deficient-microbiome and then fed either a HF or HF + RR diet plus 20% fructose water with or without G. uro for 7 weeks. Results Feeding a HF diet increased body weight and fat mass for both GF and CVZ mice compared to feeding a LF diet (P < 0.05). Feeding a HF diet with RR polyphenols significantly decreased visceral adipose tissue and liver triglycerides (P < 0.05) compared to a HF control diet in CVZ but not GF mice. G. uro administration to mice receiving a HF diet and fructose water significantly reduced body weight, body fat percentage, fasting blood glucose, and subcutaneous adipose tissue mass as well as increased ileal tight junction protein gene expression (P < 0.05) compared to controls. Notably, mice supplemented with both G. uro and RR polyphenols experienced no metabolic improvements compared to controls (P < 0.05). Conclusions Our results demonstrate that the microbiome is required for mediating RR polyphenol metabolic benefits. Supplementation of G. uro improved metabolic health; however, those beneficial effects were abrogated in the presence of RR polyphenols. Together, these results highlight the importance of considering specific diet-microbiota interactions when developing foods for preventing and treating obesity-related diseases. Funding Sources USDA NIFA.

Urolithins Attenuate Multiple Symptoms of Obesity in Rats Fed on a High-Fat Diet

Effects of Urolithins on Obesity-Associated Gut Dysbiosis in Rats Fed on a High-Fat Diet.

The Utilization of Urolithin A—A Natural Polyphenol Metabolite of Ellagitannins As a Modulator of the Gut Microbiota for Its Potential Use in Obesity Therapy

Urolithin B Protects Mice from Diet-Induced Obesity, Insulin Resistance, and Intestinal Inflammation by Regulating Gut Microbiota Composition.

Comparative Analysis of the Impact of Urolithins on the Composition of the Gut Microbiota in Normal-Diet Fed Rats

Gut microbial metabolite urolithin B protects from insulin resistance and intestinal inflammation in association reshaping gut microbiota of obseity mice

Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice

Uridine Attenuates Obesity, Ameliorates Hepatic Lipid Accumulation and Modifies the Gut Microbiota Composition in Mice Fed with a High-Fat Diet

Urolithin A production drives the pomegranate effects on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals

Urolithin A Shows Anti-Atherosclerotic Activity Via Activation of Class B Scavenger Receptor and Activation of Nef2 Signaling Pathway

Urolithin A Promotes Atherosclerotic Plaque Stability by Limiting Inflammation and Hypercholesteremia in Apolipoprotein E–deficient Mice

Ursolic acid ameliorates obesity of mice fed with high-fat diet via alteration of gut microbiota and amino acid metabolism

Pancreas Protective Effects of Urolithin A on Type 2 Diabetic Mice Induced by High Fat and Streptozotocin Via Regulating Autophagy and AKT/mTOR Signaling Pathway.

A mechanistic insight into the biological activities of urolithins as gut microbial metabolites of ellagitannins

The Gut Microbiota Regulates the Metabolic Benefits Mediated by Red Raspberry Polyphenols

Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes

Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases

Ameliorative Effect of Urolithin A Ond-Gal-induced Liver and Kidney Damage in Aging Miceviaits Antioxidative, Anti-Inflammatory and Antiapoptotic Properties

Urolithin A Attenuates Ox‐ldl‐induced Endothelial Dysfunction Partly by Modulating Microrna‐27 and ERK/PPAR‐γ Pathway

In vivo administration of gut bacterial consortia replicates urolithin metabotypes A and B in a non-urolithin-producing rat model

Gut Microbial Metabolite Urolithin B Attenuates Intestinal Immunity Function in Vivo in Aging Mice and in Vitro in HT29 Cells by Regulating Oxidative Stress and Inflammatory Signalling.